ahlam1399
05-30-2015, 04:50 PM
J&J multiple myeloma drug offers hope after others stop working -study
May 30 (Reuters) - An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46c8404c/sc/19/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=w-eeRtORltQ:GdXyIk8Tvo8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=w-eeRtORltQ:GdXyIk8Tvo8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/w-eeRtORltQ
May 30 (Reuters) - An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46c8404c/sc/19/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=w-eeRtORltQ:GdXyIk8Tvo8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=w-eeRtORltQ:GdXyIk8Tvo8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=w-eeRtORltQ:GdXyIk8Tvo8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/w-eeRtORltQ